<DOC>
	<DOCNO>NCT01370408</DOCNO>
	<brief_summary>In study , patient receive ondansetron 8mg dexamethasone 10mg intravenously 30 minute prior myeloablative preparative chemotherapy last day chemotherapy . On final day chemotherapy , palonosetron 0.25mg dexamethasone 10mg administer intravenously 30 minute prior chemotherapy . If chemotherapy regimen 1 day chemotherapy palonosetron dexamethasone administer 30 minute prior chemotherapy . Dexamethasone 8mg daily give orally 2 day follow chemotherapy .</brief_summary>
	<brief_title>Palonosetron , Ondansetron , Dexamethasone Delayed Nausea Vomiting Autologous Transplant Patients</brief_title>
	<detailed_description>In order decrease delay CINV , investigator develop unique schedule antiemetic take advantage palonosetron 's long elimination half-life ( 40 hour ) . In study , patient receive ondansetron 8mg dexamethasone 10mg intravenously 30 minute prior myeloablative preparative chemotherapy last day chemotherapy . On final day chemotherapy , palonosetron 0.25mg dexamethasone 10mg administer intravenously 30 minute prior chemotherapy . If chemotherapy regimen 1 day chemotherapy palonosetron dexamethasone administer 30 minute prior chemotherapy . Dexamethasone 8mg daily give orally 2 day follow chemotherapy . The investigator hypothesize antiemetic schedule significantly reduce delay CINV compare historical control</detailed_description>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Palonosetron</mesh_term>
	<criteria>candidate highdose chemotherapy autologous hematopoietic stem cell transplantation Karnofsky performance status &gt; /= 60 % schedule receive one follow conditioning regimen BEAM Oral Busulfan/cyclophosphamide without etoposide Carboplatin/Etoposide Melphalan Negative pregnancy test Must able complete daily nausea/vomiting questionnaire Quality Life Active infection require IV antibiotic Known active hepatitis B and/or hepatitis C HIV infection prior nonhematological malignancy sit except surgically treat nonmelanoma skin cancer , superficial cervical cancer cancer patient disease free &gt; /= 5 year Uncontrolled medical problem include follow Diabetes mellitus Cardiac , pulmonary , hepatic renal disease myocardial infarction within past 6 month Morbid obesity ( BMT &gt; 40 ) History CNS metastasis , psychiatric CNS disorder interfere ability comply study Known hypersensitivity 5HT3 antagonist , dexamethasone and/or component Intrathecal therapy within 24 hour start preparative regimen Receiving antiemetic therapy 24 hour start preparative regimen Any 5HT3 antagonist use rescue medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Autologous stem cell transplant</keyword>
	<keyword>BEAM</keyword>
	<keyword>Oral busulfan</keyword>
	<keyword>Cyclophosphamide</keyword>
	<keyword>Etoposide</keyword>
	<keyword>Carboplatin</keyword>
	<keyword>melphalan</keyword>
</DOC>